Clinical Trials Logo

Clinical Trial Summary

The researchers are doing this study to find out whether hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) is a safe treatment that causes few or mild side effects in people with pleural metastases from thymic malignancies. The researchers will also look at whether hemithoracic IMPRINT is effective against participants' cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05354570
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact Annemarie Shepherd, MD
Phone 908-542-3430
Email shephera@mskcc.org
Status Recruiting
Phase Phase 2
Start date April 26, 2022
Completion date April 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed NCT01163552 - Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity Phase 2
Completed NCT04200417 - Chemoembolization for Lung Tumors Phase 1